With regard to the potential therapeutic approach of restoring UNC13A expression with a splice-correcting antisense oligonucleotide in individuals with ALS associated with TDP-43 pathology (Keuss et al, 2024), it may also be important to take into account the potential overexpression of REST in motor neurons of such patients. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.